Specialised Therapeutics Australia Release: ABRAXANE® Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients
10/25/2012 10:44:05 AM
More...
|
Optimer Pharmaceuticals, Inc. (OPTR) and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
6/19/2012 11:52:53 AM
More...
|
Specialised Therapeutics Australia Release: World Leading Breast Cancer Drug Now Available in New Zealand
2/22/2011 10:41:13 AM
More...
|
Abraxis BioScience, Inc. and Specialised Therapeutics Australia Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand
7/29/2010 8:04:43 AM
More...
|
Abraxis BioScience, Inc. and Specialised Therapeutics Australia Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in Australia
10/16/2008 10:08:00 AM
More...
|